COVID Proves Clinical Trials Must Proactively Recruit People of Color
Jo Wiederhorn, President and CEO of the Associated Medical Schools of New York (AMSNY), writes in The Hill about the need to diversify clinical trial patient groups through proactive recruitment and reducing barriers. Take a closer look.
|